Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Insiders Buying Blend Labs And 3 Other Stocks Under $2

Published 14/11/2023, 11:45
© Reuters.  Insiders Buying Blend Labs And 3 Other Stocks Under $2

Benzinga - by Lisa Levin, Benzinga Editor.

The Dow Jones closed higher by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Marchex

  • The Trade: Marchex, Inc. (NASDAQ: MCHX) 10% owner Jonathan Brolin acquired a total of 26,975 shares an average price of $1.40. To acquire these shares, it cost around $37,714.
  • What’s Happening: Marchex posted a narrower-than-expected quarterly loss.
  • What Marchex Does: Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business.
Lexicon Pharmaceuticals
  • The Trade: Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) CEO Lonnel Coats acquired a total of 10,000 shares at an average price of $1.01. To acquire these shares, it cost around $10,100.
  • What’s Happening: Lexicon Pharmaceuticals posted in-line loss for its third quarter.
  • What Lexicon Pharmaceuticals Does: Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases.

Blend Labs

  • The Trade: Blend Labs, Inc. (NYSE: BLND) Head of Finance and Admin. Amir Jafari acquired a total of 12,610 shares at an average price of $1.22. The insider spent around $15,350 to buy those shares.
  • What’s Happening: Blend Labs posted upbeat third-quarter sales.
  • What Blend Labs Does: Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
ESS Tech
  • The Trade: ESS Tech, Inc. (NYSE: GWH) Director Harry Quarls acquired a total of 46,814 shares at an average price of $1.10. The insider spent around $51,631 to buy those shares. The company’s Director Teamey Kyle also bought 1,000 shares.
  • What’s Happening: ESS Tech posted a narrower-than-expected loss for the third quarter.
  • What ESS Tech Does: ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology.

Don’t forget to check out our premarket coverage here

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.